Alexander Glaros, M.D. – FDA Inspection, Jul 17, 2026

Record Details

This FDA Inspection record concerns Alexander Glaros, M.D., with an inspection on July 17, 2026, issued by the Detroit District Office, covering human drugs.

Company: Alexander Glaros, M.D.
Inspection Date: July 17, 2026
Product Type: Human Drugs
Office: Detroit District Office
People: Dina A. Tallman (Company Rep)
Jason Woodward (Issuing Officer)

View Company Profile

ID · 1fb90c4f-6a41-4e86-83a4-96d928ba8f46

Inspection Facts

Inspection number: 1326688
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alexander Glaros, M.D.

FDA Inspection

Alexander Glaros, M.D.July 17, 2026